Regulatory considerations in drug development for autism spectrum disorders
- PMID: 33773885
- DOI: 10.1016/j.euroneuro.2021.03.002
Regulatory considerations in drug development for autism spectrum disorders
Keywords: Autism; Clinical trials; Drug development; Regulatory.
Conflict of interest statement
Declaration of Competing Interest The Authors declare no conflict of interest.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
